Raper S E, Kothary P C, DelValle J
Department of Surgery, University of Michigan Medical School, Ann Arbor 48109-0331.
Hepatology. 1992 Aug;16(2):433-9. doi: 10.1002/hep.1840160223.
Binding of somatostatin-14 to rat liver plasma membranes was characterized with 125-labeled[tyr11] somatostatin-14. Binding at 24 degrees C reached a plateau at 50 min and was reversible by synthetic somatostatin-14. Scatchard analysis revealed a single class of binding sites (affinity constant = 2.4 +/- 0.2 nmol/L, binding capacity = 148 +/- 0.02 fmol/mg protein). Specificity for somatostatin-14 was demonstrated by the inhibition of 125I-[tyr11]somatostatin-14 binding by biologically active somatostatin analogs but not by a biologically inactive somatostatin analog or unrelated peptides. The radioiodinated binding site complex could be cross-linked with disuccinimidyl suberate. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel autoradiography revealed a 70,000-Da band. Dithiothreitol, a reducing reagent, did not alter the mobility of the band, and the band could be abolished in the presence of 10 mumol/L synthetic somatostatin-14. Covalently cross-linked, iodinated binding protein complexes could be solubilized by the nonreducing detergents Zwittergent 3-12 and 3-([3-cholamidopropyl] diethylammonio)-1-propanesulfonic acid (CHAPS). Solubilized complex bound to wheat-germ agglutinin-agarose columns and was eluted by N,N',N"-triacetylchitotriose. Binding to wheat-germ agglutinin agarose columns was lost after pretreatment with endo-beta-N-acetylglucosaminidase F. Binding studies with liver plasma membranes, 125I-labeled[tyrosine11]somatostatin-14 and guanine nucleotides showed inhibition of binding in the presence of guanine nucleotides. These results indicate that the purified rat liver plasma membranes contain a specific binding protein for somatostatin-14, the binding protein appears to be glycosylated and somatostatin-14 binding to rat liver plasma membranes may be regulated by G proteins.
用125标记的[酪氨酸11]生长抑素-14对生长抑素-14与大鼠肝细胞膜的结合特性进行了研究。24℃下的结合在50分钟时达到平台期,且可被合成的生长抑素-14逆转。Scatchard分析显示存在一类结合位点(亲和常数 = 2.4±0.2 nmol/L,结合容量 = 148±0.02 fmol/mg蛋白质)。生物活性生长抑素类似物可抑制125I-[酪氨酸11]生长抑素-14的结合,而生物无活性的生长抑素类似物或无关肽则不能,这证明了对生长抑素-14具有特异性。放射性碘化的结合位点复合物可用辛二酸二琥珀酰亚胺酯进行交联。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和凝胶放射自显影分析显示有一条70,000道尔顿的条带。还原剂二硫苏糖醇不会改变该条带的迁移率,并且在存在10 μmol/L合成生长抑素-14的情况下该条带会消失。共价交联的碘化结合蛋白复合物可用非还原性去污剂两性离子去污剂3-12和3-([3-胆酰胺丙基]二乙铵基)-1-丙烷磺酸(CHAPS)溶解。溶解的复合物与麦胚凝集素-琼脂糖柱结合,并被N,N',N"-三乙酰壳三糖洗脱。用内切-β-N-乙酰葡糖胺糖苷酶F预处理后,与麦胚凝集素琼脂糖柱的结合丧失。用肝细胞膜、125I标记的[酪氨酸11]生长抑素-14和鸟嘌呤核苷酸进行的结合研究表明,在鸟嘌呤核苷酸存在的情况下结合受到抑制。这些结果表明,纯化的大鼠肝细胞膜含有一种生长抑素-14的特异性结合蛋白,该结合蛋白似乎是糖基化的,并且生长抑素-14与大鼠肝细胞膜的结合可能受G蛋白调节。